COMMUNIQUÉS West-GlobeNewswire

Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations

02/05/2024 - 07:00

Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and [...]

Communiqué de presse : Des données de vie réelle concernant Beyfortus publiées dans The Lancet montrent une réduction de 82 % des hospitalisations de nourrissons dues au VRS

02/05/2024 - 07:00

Des données de vie réelle concernant Beyfortus publiées dans The Lancet montrent une réduction de 82 % des hospitalisations de nourrissons dues au VRS De nouvelles données de vie réelle montrent que Beyfortus ( [...]

Interim Report Q1 2024: GN Store Nord delivered organic revenue growth of 5% reaching an EBITA margin of 12.5%

02/05/2024 - 06:59

Highlights GN delivered continued execution across the three divisions resulting in 5% organic revenue growth for the Group The Hearing division delivered continued market share gains leading to 14% organic revenue [...]

CARBIOS and Hündgen enter supply agreement for world’s first PET biorecycling plant

02/05/2024 - 06:45

CARBIOS and Hündgen enter supply agreement for world’s first PET biorecycling plant From end 2026, Hündgen will supply 15kt/year of post-consumer PET flakes to CARBIOS’ first commercial plant Clermont-Ferrand, France, [...]

CARBIOS et Hündgen concluent un accord d’approvisionnement pour la première usine de biorecyclage du PET au monde

02/05/2024 - 06:45

CARBIOS et Hündgen concluent un accord d’approvisionnement pour la première usine de biorecyclage du PET au monde A partir de fin 2026, Hündgen fournira 15kt/an de paillettes de PET post-consommation à la première usine [...]

Three Pivotal Drug Policy Organizations Hold Media Briefing/Q&A on DEA Rescheduling of Cannabis

01/05/2024 - 23:54

Executives from MAPS, NORML, and MPP to Celebrate DEA Rescheduling of Cannabis to Schedule III Drug and Debunk Myths WASHINGTON, May 01, 2024 (GLOBE NEWSWIRE) -- What: The Multidisciplinary Association for Psychedelic [...]

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/05/2024 - 23:50

RESEARCH TRIANGLE PARK, N.C., May 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for 2,100 [...]

Pennant Acquires Senior Living Community in Idaho

01/05/2024 - 23:32

EAGLE, Idaho, May 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced [...]

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/05/2024 - 23:30

NEW YORK and SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule [...]

Pennant Acquires Utah Home Health and Hospice Provider

01/05/2024 - 23:09

EAGLE, Idaho, May 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced [...]

TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering

01/05/2024 - 23:07

FORT WORTH, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing and commercializing [...]

HiberCell Announces First Patient Dosed in Clinical Collaboration with Merck, Evaluating HC-7366 in Combination with WELIREG® (belzutifan) in patients with advanced ccRCC

01/05/2024 - 23:00

BOSTON, May 01, 2024 (GLOBE NEWSWIRE) -- HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis, and resistance, is pleased to announce the dosing of the [...]

SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results

01/05/2024 - 23:00

NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a [...]

Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

01/05/2024 - 23:00

IRVINE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients [...]

Emergent BioSolutions Reports First Quarter 2024 Financial Results

01/05/2024 - 22:57

First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance range First Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of $66.9 million Updates FY 2024 guidance GAITHERSBURG, Md., May 01, [...]

Teladoc Health Is Providing Free Virtual Health Care Services to Oklahoma Residents Impacted by Tornadoes

01/05/2024 - 22:50

PURCHASE, NY, May 01, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, is providing free, 24/7 general medical telehealth visits to Oklahoma residents, first [...]

STERIS Announces Dividend of $0.52 per share

01/05/2024 - 22:30

DUBLIN, IRELAND, May 01, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is [...]

ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences

01/05/2024 - 22:30

BAUDETTE, Minn., May 01, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, [...]

Coherus to Report First Quarter 2024 Financial Results on May 9, 2024

01/05/2024 - 22:30

REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that its first quarter 2024 financial results will be released after market close on Thursday, [...]